Literature DB >> 27638289

Effects of initial disease status on lymph flow following gastrectomy in cases of carcinoma in the remnant stomach.

Shinsaku Honda1, Etsuro Bando1, Rie Makuuchi1, Masanori Tokunaga1, Yutaka Tanizawa1, Taiichi Kawamura1, Teiichi Sugiura2, Yusuke Kinugasa2, Katsuhiko Uesaka2, Masanori Terashima3.   

Abstract

PURPOSE: In cases of carcinoma in the remnant stomach (CRS), the lymphatic flow may be altered by the initial surgery. In this study of CRS after gastrectomy, we investigated how the regions of lymph node metastasis and changes in lymphatic flow depend on initial disease status.
METHOD: The study included 76 patients with CRS who underwent gastrectomy between September 2002 and November 2014. We analyzed and compared the clinicopathological factors and survival periods between patients after distal gastrectomy for malignant disease (group M, 33 patients) and patients after distal gastrectomy for benign disease (group B, 43 patients).
RESULTS: The depth of tumor invasion was more advanced in group B (T1/T2/T3/T4: group M 18/1/7/7, group B 8/11/8/16; P = 0.002). However, the degree of lymph node metastasis did not differ significantly between the two groups. The incidence of lymph node metastasis was high at stations 2 (19 %), 4sa (17 %), 10 (25 %), 11p (19 %), and 11d (27 %) in group M and 1 (14 %), 3 (23 %), and 4sb (15 %), and the mesojejunal lymph node (21 %) in group B. Lymph node dissection was highly beneficial at station 3, station 7, and the mesojejunum in both groups, but not at stations 10 or 11d.
CONCLUSION: As compared with group B, group M showed higher incidences of lymph node metastasis in the greater curvature, splenic hilum, and lymph nodes along the splenic artery, suggesting the predominance of lymphatic flows from the greater curvature to the splenic hilum and from the remnant stomach to the splenic artery.

Entities:  

Keywords:  Carcinoma in the remnant stomach; Lymphatic flow; Splenectomy

Mesh:

Year:  2016        PMID: 27638289     DOI: 10.1007/s10120-016-0640-2

Source DB:  PubMed          Journal:  Gastric Cancer        ISSN: 1436-3291            Impact factor:   7.370


  26 in total

1.  Clinicopathologic differences between early gastric remnant cancer and early primary gastric cancer in the upper third of the stomach.

Authors:  T Imada; Y Rino; S Hatori; M Shiozawa; M Takahashi; T Amano; J Kondo; O Kobayashi; M Sairenji; H Motohashi
Journal:  Hepatogastroenterology       Date:  2000 Jul-Aug

2.  Japanese classification of gastric carcinoma: 3rd English edition.

Authors: 
Journal:  Gastric Cancer       Date:  2011-06       Impact factor: 7.370

3.  Japanese gastric cancer treatment guidelines 2010 (ver. 3).

Authors: 
Journal:  Gastric Cancer       Date:  2011-06       Impact factor: 7.370

4.  Metastatic pattern of lymph node and surgery for gastric stump cancer.

Authors:  Shao-Liang Han; Ya-Wei Hua; Cheng-Hu Wang; She-Qing Ji; Jing Zhuang
Journal:  J Surg Oncol       Date:  2003-04       Impact factor: 3.454

5.  Risk factors for metachronous gastric cancer in the remnant stomach after early cancer surgery.

Authors:  Isao Nozaki; Junichirou Nasu; Yoshiro Kubo; Minoru Tanada; Rieko Nishimura; Akira Kurita
Journal:  World J Surg       Date:  2010-07       Impact factor: 3.352

6.  Cancer of the gastric stump following distal gastrectomy for cancer.

Authors:  M Ohashi; H Katai; T Fukagawa; T Gotoda; T Sano; M Sasako
Journal:  Br J Surg       Date:  2007-01       Impact factor: 6.939

7.  Progression of remnant gastric cancer is associated with duration of follow-up following distal gastrectomy.

Authors:  Shuhei Komatsu; Daisuke Ichikawa; Kazuma Okamoto; Daito Ikoma; Masahiro Tsujiura; Yukihisa Nishimura; Yasutoshi Murayama; Atsushi Shiozaki; Hisashi Ikoma; Yoshiaki Kuriu; Masayoshi Nakanishi; Hitoshi Fujiwara; Toshiya Ochiai; Yukihito Kokuba; Eigo Otsuji
Journal:  World J Gastroenterol       Date:  2012-06-14       Impact factor: 5.742

8.  Surgical treatment of non-early gastric remnant carcinoma developing after distal gastrectomy for gastric cancer.

Authors:  Masaki Ohashi; Shinji Morita; Takeo Fukagawa; Ryoji Kushima; Hitoshi Katai
Journal:  J Surg Oncol       Date:  2014-08-30       Impact factor: 3.454

9.  Surgical outcome of 483 patients with early gastric cancer: prognosis, postoperative morbidity and mortality, and gastric remnant cancer.

Authors:  Hiroyuki Onodera; Akira Tokunaga; Toshiro Yoshiyuki; Teruo Kiyama; Shunji Kato; Norio Matsukura; Gotaro Masuda; Takashi Tajiri
Journal:  Hepatogastroenterology       Date:  2004 Jan-Feb

10.  Randomized Controlled Trial to Evaluate Splenectomy in Total Gastrectomy for Proximal Gastric Carcinoma.

Authors:  Takeshi Sano; Mitsuru Sasako; Junki Mizusawa; Seiichiro Yamamoto; Hitoshi Katai; Takaki Yoshikawa; Atsushi Nashimoto; Seiji Ito; Masahide Kaji; Hiroshi Imamura; Norimasa Fukushima; Kazumasa Fujitani
Journal:  Ann Surg       Date:  2017-02       Impact factor: 12.969

View more
  4 in total

1.  Comparison of total versus subtotal gastrectomy for remnant gastric cancer.

Authors:  Hironobu Goto; Shingo Kanaji; Dai Otsubo; Taro Oshikiri; Masashi Yamamoto; Tetsu Nakamura; Satoshi Suzuki; Yasuhiro Fujino; Masahiro Tominaga; Yoshihiro Kakeji
Journal:  Langenbecks Arch Surg       Date:  2019-09-04       Impact factor: 3.445

2.  Incidence of adhesive small bowel obstruction after gastrectomy for gastric cancer and its risk factors: a long-term retrospective cohort study from a high-volume institution in China.

Authors:  Tao Pan; Danil Galiullin; Xiao-Long Chen; Wei-Han Zhang; Kun Yang; Kai Liu; Lin-Yong Zhao; Xin-Zu Chen; Jian-Kun Hu
Journal:  Updates Surg       Date:  2021-02-06

3.  Different risks of nodal metastasis by tumor location in remnant gastric cancer after curative gastrectomy for gastric cancer.

Authors:  Kazuya Takahashi; Takaki Yoshikawa; Shinji Morita; Takahiro Kinoshita; Masahiro Yura; Sho Otsuki; Masanori Tokunaga; Yukinori Yamagata; Akio Kaito; Hitoshi Katai
Journal:  Gastric Cancer       Date:  2019-07-13       Impact factor: 7.370

Review 4.  Disadvantages of Complete No. 10 Lymph Node Dissection in Gastric Cancer and the Possibility of Spleen-Preserving Dissection: Review.

Authors:  Tetsuro Toriumi; Masanori Terashima
Journal:  J Gastric Cancer       Date:  2020-02-27       Impact factor: 3.720

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.